FDA Inspection 949237 — University Of Texas MD Anderson Cancer Center
The FDA completed an inspection of University Of Texas MD Anderson Cancer Center on October 27, 2015 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 27, 2015
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Houston, TX (United States)